References
- Johnson R. Osteitis pubis. Curr Sports Med Rep 2003;2:98–102.
- Verrall GM, Slavotinek JP, Fon GT. Australian rules football players: relation to groin incidence of pubic bone marrow oedema in Pain. Br J Sports Med 2001;35:28–33.
- Rodriguez C, Miguel A, Lima H, Heinrichs K. Osteitis pubis syndrome in the professional soccer athlete: a case report. J Athl Train 2001;36:437–40.
- Choi H, McCartney M, Best TM. Treatment of osteitis pubis and osteomyelitis of the pubic symphysis in athletes: a systematic review. Br J Sports Med 2008;45(1):57–64.
- Slobodin G, Rosner I, Feld J, Rimar D, Rozenbaum M, Boulman N, et al. Pamidronate treatment in rheumatology practice: a comprehensive review. Clin Rheumatol 2009;28:1359–64.
- Agarwala S, Jain D, Joshi VR, Sule A. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology (Oxford) 2005;44:352–9.
- Maksymowych WP, Aaron SL, Russell AS. Treatment of refractory symphysitis pubis with intravenous pamidronate. J Rheumatol 2001;28:2754–7.
- Halvorson KG, Sevcik MA, Ghilardi JR, Sullivan LJ, Koewler NJ, Bauss F, et al. Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer. J Pain Symptom Manage 2008;36(3):289–303, doi:10.1016/j.jpainsymman.2007.10.005 [Epub 2008 Apr 14]. PubMed PMID: 18411018; PubMed Central PMCID: PMC2638081.
- Suresh E, Pazianas M, Abrahamsen B. Safety issues with bisphosphonate therapy for osteoporosis. Rheumatology (Oxford) 2014;53(1):19–31, doi:10.1093/rheumatology/ket236 [Epub 2013 Jul 9].